Structural Heart Disease

Structural heart diseases include any issues preventing normal cardiovascular function due to damage or alteration to the anatomical components of the heart. This is caused by aging, advanced atherosclerosis, calcification, tissue degeneration, congenital heart defects and heart failure. The most commonly treated areas are the heart valves, in particular the mitral and aortic valves. These can be replaced through open heart surgery or using cath lab-based transcatheter valves or repairs to eliminate regurgitation due to faulty valve leaflets. This includes transcatheter aortic valve replacement (TAVR). Other common procedures include left atrial appendage (LAA) occlusion and closing congenital holes in the heart, such as PFO and ASD. A growing area includes transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

Self-expanding TAVR system gains approval for high-risk patients in China

The National Medical Products Administration reviewed data from more than 32,000 patients to make its decision.

overnight night shift attending radiologist burnout

Researchers take a fresh look at how different risk factors impact the look of a patient's heart

The study included cardiac MRI scans of nearly 30,000 patients. 

Edwards gains FDA approval for new Sapien 3 solution for TPV replacement

The system was designed to treat both pediatric and adult patients.

Thumbnail

AI improves detection of severe CAD in stress echocardiograms

Advanced algorithms can lead to significant improvements in agreement among specialists, researchers found. 

Thumbnail

Prosthetic-patient mismatch after TAVR much less likely among Asian patients

Patient outcomes, it seems, are not significantly impacted by this trend. 

Thumbnail

Pre-TAVR pulmonary artery dilatation helps identify high-risk patients

Imaging-based PAD may provide value as a noninvasive alternative to right heart catheterization. 

Thumbnail

TTVR patients see consistent improvements in their daily lives

Researchers evaluated 115 patients before and one month after undergoing transcatheter tricuspid valve repair, sharing their findings in JACC: Cardiovascular Interventions

Thumbnail

Pressure-regulated THV deployment could provide significant value

Overall, researchers found, this method was “simple, reproducible, safe and effective.”